Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

Europe - EPA:EXPL - FR0014003AQ4 - Common Stock

193.5 EUR
+1 (+0.52%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPL. EXPL was compared to 69 industry peers in the Chemicals industry. While EXPL has a great profitability rating, there are some minor concerns on its financial health. EXPL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
In the past year EXPL had a positive cash flow from operations.
Of the past 5 years EXPL 4 years were profitable.
EXPL had a positive operating cash flow in each of the past 5 years.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 4.98%, EXPL is doing good in the industry, outperforming 72.46% of the companies in the same industry.
EXPL has a better Return On Equity (14.04%) than 79.71% of its industry peers.
The Return On Invested Capital of EXPL (6.36%) is better than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPL is in line with the industry average of 7.19%.
The 3 year average ROIC (6.01%) for EXPL is below the current ROIC(6.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

EXPL's Profit Margin of 4.77% is fine compared to the rest of the industry. EXPL outperforms 60.87% of its industry peers.
EXPL's Profit Margin has improved in the last couple of years.
The Operating Margin of EXPL (4.22%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXPL has grown nicely.
With an excellent Gross Margin value of 60.41%, EXPL belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
EXPL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPL is destroying value.
Compared to 1 year ago, EXPL has more shares outstanding
Compared to 5 years ago, EXPL has more shares outstanding
EXPL has a better debt/assets ratio than last year.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPL has an Altman-Z score of 2.66. This is not the best score and indicates that EXPL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of EXPL (2.66) is better than 62.32% of its industry peers.
EXPL has a debt to FCF ratio of 2.38. This is a good value and a sign of high solvency as EXPL would need 2.38 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.38, EXPL belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
EXPL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, EXPL perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.66
ROIC/WACC0.85
WACC7.51%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

EXPL has a Current Ratio of 1.26. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, EXPL is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
EXPL has a Quick Ratio of 1.26. This is a bad value and indicates that EXPL is not financially healthy enough and could expect problems in meeting its short term obligations.
EXPL has a Quick ratio (0.94) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

EXPL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.64%, which is quite good.
The Earnings Per Share has been growing by 51.47% on average over the past years. This is a very strong growth
EXPL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.64%.
Measured over the past years, EXPL shows a small growth in Revenue. The Revenue has been growing by 7.27% on average per year.
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%

3.2 Future

The Earnings Per Share is expected to grow by 17.78% on average over the next years. This is quite good.
EXPL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.51% yearly.
EPS Next Y20.22%
EPS Next 2Y21.79%
EPS Next 3Y17.78%
EPS Next 5YN/A
Revenue Next Year10.5%
Revenue Next 2Y8.49%
Revenue Next 3Y6.51%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.53, EXPL is valued on the expensive side.
Based on the Price/Earnings ratio, EXPL is valued a bit cheaper than 63.77% of the companies in the same industry.
EXPL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.13 indicates a correct valuation of EXPL.
EXPL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPL is cheaper than 69.57% of the companies in the same industry.
EXPL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 17.53
Fwd PE 13.13
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, EXPL is valued cheaper than 89.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.77
EV/EBITDA 10.65
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPL has a very decent profitability rating, which may justify a higher PE ratio.
EXPL's earnings are expected to grow with 17.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y21.79%
EPS Next 3Y17.78%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.74%, EXPL is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.22, EXPL is paying slightly less dividend.
With a Dividend Yield of 0.74, EXPL pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

EXPL pays out 9.03% of its income as dividend. This is a sustainable payout ratio.
DP9.03%
EPS Next 2Y21.79%
EPS Next 3Y17.78%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (10/16/2025, 7:00:00 PM)

193.5

+1 (+0.52%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-29 2025-09-29
Earnings (Next)N/A N/A
Inst Owners3.75%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap437.31M
Analysts82.86
Price Target221.34 (14.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.7%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.06%
Revenue NY rev (3m)7.06%
Valuation
Industry RankSector Rank
PE 17.53
Fwd PE 13.13
P/S 0.89
P/FCF 10.77
P/OCF 6.52
P/B 2.63
P/tB 2.92
EV/EBITDA 10.65
EPS(TTM)11.04
EY5.71%
EPS(NY)14.74
Fwd EY7.62%
FCF(TTM)17.96
FCFY9.28%
OCF(TTM)29.69
OCFY15.34%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)0.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.66
F-Score6
WACC7.51%
ROIC/WACC0.85
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
EPS Next Y20.22%
EPS Next 2Y21.79%
EPS Next 3Y17.78%
EPS Next 5YN/A
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%
Revenue Next Year10.5%
Revenue Next 2Y8.49%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year88.7%
EBIT Next 3Y32.83%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%